Suzanne V Arnold1,2, Kasia J Lipska3, Jingyan Wang1,2, Leo Seman4, Sanjeev N Mehta5, Mikhail Kosiborod1,2. 1. Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, Missouri. 2. University of Missouri-Kansas City, Kansas City, Missouri. 3. Section of Endocrinology, Dept of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut. 4. Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut. 5. Joslin Diabetes Center, Boston, Massachusetts.
Abstract
OBJECTIVES: To examine the proportion of older adults with diabetes mellitus treated with tight glucose control and the factors associated with this practice. DESIGN: Cross-sectional analysis. SETTING: Outpatient sites in the Diabetes Collaborative Registry (N=151). PARTICIPANTS: Adults aged 75 and older with type 2 diabetes mellitus (N=42,669). MEASUREMENTS: Participants were categorized based on glycosylated hemoglobin (HbA1c) and glucose-lowering medications: poor control (HbA1c >9%), moderate control (HbA1c 8-9%), conservative control (HbA1c 7-8%), tight control (HbA1c <7%) with low-risk agents (low risk for hypoglycemia), tight control with high-risk agents, and diet control (HbA1c <7% taking no glucose-lowering medications). We used hierarchical logistic regression to examine participant and site factors associated with tight control and high-risk agents versus conservative or tight control and low-risk agents. RESULTS: Of 30,696 participants without diet-controlled diabetes, 5,596 (18%) had moderate or poor control, 9,227 (30%) had conservative control, 7,893 (26%) had tight control taking low-risk agents, and 7,980 (26%) had tight control taking high-risk agents. Older age, male sex, heart failure, chronic kidney disease, and coronary artery disease were each independently associated with greater odds of tight control with high-risk agents. There were no differences according to practice specialty (endocrinology, primary care, cardiology) in how aggressively participants were managed. CONCLUSION: One-quarter of U.S. older adults with type 2 diabetes mellitus are tightly controlled with glucose-lowering medications that have a high risk of hypoglycemia. These results suggest potential overtreatment of a substantial proportion of people and should encourage further efforts to translate guidelines to daily practice.
OBJECTIVES: To examine the proportion of older adults with diabetes mellitus treated with tight glucose control and the factors associated with this practice. DESIGN: Cross-sectional analysis. SETTING:Outpatient sites in the Diabetes Collaborative Registry (N=151). PARTICIPANTS: Adults aged 75 and older with type 2 diabetes mellitus (N=42,669). MEASUREMENTS: Participants were categorized based on glycosylated hemoglobin (HbA1c) and glucose-lowering medications: poor control (HbA1c >9%), moderate control (HbA1c 8-9%), conservative control (HbA1c 7-8%), tight control (HbA1c <7%) with low-risk agents (low risk for hypoglycemia), tight control with high-risk agents, and diet control (HbA1c <7% taking no glucose-lowering medications). We used hierarchical logistic regression to examine participant and site factors associated with tight control and high-risk agents versus conservative or tight control and low-risk agents. RESULTS: Of 30,696 participants without diet-controlled diabetes, 5,596 (18%) had moderate or poor control, 9,227 (30%) had conservative control, 7,893 (26%) had tight control taking low-risk agents, and 7,980 (26%) had tight control taking high-risk agents. Older age, male sex, heart failure, chronic kidney disease, and coronary artery disease were each independently associated with greater odds of tight control with high-risk agents. There were no differences according to practice specialty (endocrinology, primary care, cardiology) in how aggressively participants were managed. CONCLUSION: One-quarter of U.S. older adults with type 2 diabetes mellitus are tightly controlled with glucose-lowering medications that have a high risk of hypoglycemia. These results suggest potential overtreatment of a substantial proportion of people and should encourage further efforts to translate guidelines to daily practice.
Authors: Kasia J Lipska; Joseph S Ross; Yinghui Miao; Nilay D Shah; Sei J Lee; Michael A Steinman Journal: JAMA Intern Med Date: 2015-03 Impact factor: 21.873
Authors: Faramarz Ismail-Beigi; Etie Moghissi; Margaret Tiktin; Irl B Hirsch; Silvio E Inzucchi; Saul Genuth Journal: Ann Intern Med Date: 2011-04-19 Impact factor: 25.391
Authors: Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil Journal: N Engl J Med Date: 2008-09-10 Impact factor: 91.245
Authors: Kasia J Lipska; Joseph S Ross; Yun Wang; Silvio E Inzucchi; Karl Minges; Andrew J Karter; Elbert S Huang; Mayur M Desai; Thomas M Gill; Harlan M Krumholz Journal: JAMA Intern Med Date: 2014-07 Impact factor: 21.873
Authors: M Sue Kirkman; Vanessa Jones Briscoe; Nathaniel Clark; Hermes Florez; Linda B Haas; Jeffrey B Halter; Elbert S Huang; Mary T Korytkowski; Medha N Munshi; Peggy Soule Odegard; Richard E Pratley; Carrie S Swift Journal: Diabetes Care Date: 2012-10-25 Impact factor: 19.112
Authors: Theresa A Rowe; Tiffany Brown; Ji Young Lee; Jeffrey A Linder; Mark W Friedberg; Jason N Doctor; Daniella Meeker; Jody D Ciolino; Stephen D Persell Journal: J Gen Intern Med Date: 2020-03-03 Impact factor: 5.128
Authors: Boris Draznin; Vanita R Aroda; George Bakris; Gretchen Benson; Florence M Brown; RaShaye Freeman; Jennifer Green; Elbert Huang; Diana Isaacs; Scott Kahan; Jose Leon; Sarah K Lyons; Anne L Peters; Priya Prahalad; Jane E B Reusch; Deborah Young-Hyman Journal: Diabetes Care Date: 2022-01-01 Impact factor: 19.112
Authors: Kathryn E Callahan; Kristin M Lenoir; Chinenye O Usoh; Jeff D Williamson; LaShanda Y Brown; Adam W Moses; Molly Hinely; Zeev Neuwirth; Nicholas M Pajewski Journal: Diabetes Spectr Date: 2022-03-21
Authors: S Akin; C Bölük; Y Ozgur; N Aladağ; G Geçmez; O Keskin; U Turk Boru; M Tasdemir Journal: Acta Endocrinol (Buchar) Date: 2019 Jul-Sep Impact factor: 0.877
Authors: Iliana C Lega; Michael A Campitelli; Peter C Austin; Yingbo Na; Afshan Zahedi; Freda Leung; Catherine Yu; Susan E Bronskill; Paula A Rochon; Lorraine L Lipscombe Journal: Diabetologia Date: 2021-01-25 Impact factor: 10.122
Authors: Mary R Rooney; Olive Tang; Justin B Echouffo Tcheugui; Pamela L Lutsey; Morgan E Grams; B Gwen Windham; Elizabeth Selvin Journal: Diabetes Care Date: 2021-05-18 Impact factor: 17.152
Authors: Alan J Sinclair; Simon R Heller; Richard E Pratley; Ran Duan; Robert J Heine; Andreas Festa; Jacek Kiljański Journal: Diabetes Obes Metab Date: 2020-03-11 Impact factor: 6.577
Authors: Huberta E Hart; Kim Ditzel; Guy E Rutten; Esther de Groot; Samuel Seidu; Kamlesh Khunti; Rimke C Vos Journal: Patient Prefer Adherence Date: 2019-10-18 Impact factor: 2.711